| Plasma Cell Myeloma |
19.1% |
| Product Used For Unknown Indication |
13.9% |
| Drug Use For Unknown Indication |
12.7% |
| Multiple Sclerosis |
8.7% |
| Hodgkin's Disease |
6.4% |
| Diffuse Large B-cell Lymphoma |
4.0% |
| Precursor T-lymphoblastic Lymphoma/leukaemia |
4.0% |
| Chronic Myeloid Leukaemia |
3.5% |
| Myelodysplastic Syndrome |
2.9% |
| Peripheral T-cell Lymphoma Unspecified |
2.9% |
| Prostate Cancer Metastatic |
2.9% |
| Acute Myeloid Leukaemia |
2.3% |
| Depression |
2.3% |
| Detoxification |
2.3% |
| Hypertension |
2.3% |
| Immunodeficiency Common Variable |
2.3% |
| Tuberous Sclerosis |
2.3% |
| Acute Lymphocytic Leukaemia |
1.7% |
| Breast Cancer Metastatic |
1.7% |
| Chronic Lymphocytic Leukaemia |
1.7% |
